Anemia is a mortality predictor in hospitalized patients for copd exacerbation

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 9, Issue 3, 2012, Pages 243-250

  Martinez Rivera, Carlos ^a   Portillo, Karina ^a   Muñoz Ferrer, Aida ^a   Martínez Ortiz, María Luisa ^a   Molins, Elena ^a   Serra, Pere ^a   Ruiz Manzano, Joan ^a   Morera, Josep ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Anemia; Previous exacerbations; Prognostic factor; Survival

Indexed keywords

ALBUMIN; HEMOGLOBIN;

AGED; ANEMIA; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEATH; DISEASE EXACERBATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEMATOCRIT; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCLE MASS; NUTRITIONAL STATUS; PRIORITY JOURNAL; SURVIVOR;

AGED; AGED, 80 AND OVER; ANEMIA; DISEASE PROGRESSION; ERYTHROCYTE INDICES; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84862080305     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2011.647131     Document Type: Article

References (40)

1. Global Strategy for the Diagnosis, Management and prevention of Chronic Obstructive Pulmonary Disease 2009. Global initiative for Chronic Obstructive Lung Disease (GOLD) www. goldcopd.com.
2. Donaldson GC, Seemungal TAR, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Th orax 2002; 57(10):847-852.
3. Donaldson GC, Wilkinson TMA, Hurst JR, et al. Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171(5):446-452.
4. Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157(5Pt1):1418-1422.
5. Soler-Catalũa JJ, Martínez-García MA, Román Sánchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Th orax 2005; 60(11):925-931.
6. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363(12):1128-1138.
7. Almagro P, Calbo E, Ochoa de Echagüen A, et al. Mortality after hospitalization for copd. Chest 2002; 121(5):1441-1448.
8. Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalisation for acute exacerbation of copd. Chest 2003; 124(2): 459-467.
9. Gunen H, Hacievliyagil SS, Kosar F, et al. Factors aff ecting survival of hospitalised patients with copd. Eur Respir J 2005; 26(2):234-241.
10. Horwich TB, Fonarow GC, Hamilton MA, et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and a signifi cant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002; 39(11):1780-1786.
11. Caro JJ, Salas M, Ward A, et al. Anemia as an independent prognostic factor for survival in patients with cancer: A systemic, quantitative review. Cancer 2001; 91(12):2214-2221.
12. Silverberg DS, Wexler D, Laina A, et al. The interaction between heart failure and other heart diseases, renal failure, and anemia. Semin Nephrol 2006; 26(2):296-306.
13. Chambellan A, Chailleux E, Similowski T, ANTADIR Observatory Group. Prognostic value of hematocrit in patients with severe copd receiving long-term oxygen therapy. Chest 2005; 128(3):1201-1208.
14. John M, Hoernig S, Doehner W, et al. Anemia and infl ammation in copd. Chest 2005; 127(3):825-829.
15. John M, Lange A, Hoernig S, et al. Prevalence of anemia in chronic obstructive pulmonary disease: Comparison to other chronic diseases. Int J Cardiol 2006; 111(3):365-370.
16. Portillo K, Belda J, Antón P, et al. High frequency of anemia in copd patients admitted in a tertiary hospital. Rev Clin Esp 2007; 207(8):383-387.
17. Cote C, Zilberberg MD, Mody SH, et al. Haemoglobin level and its clinical impact in a cohort of patients with copd. Eur Respir J 2007; 29(5): 923-929.
18. Halpern MT, Zilberberg MD, Schmier JK, et al. Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost Eff Resour Alloc 2006; 16(4):17.
19. Shorr AF, Doyle J, Stern L, et al. Anemia in chronic obstructive pulmonary disease: Epidemiology and economic implications. Curr Med Res Opin 2008; 24(4):1123-1130.
20. Krishnan G, Grant BJ, Muti PC, et al. Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease. BMC Pulm Med 2006; 6: 23.
21. Lima DF, Dela Coleta K, Tanni SE, et al. Potentially modifi able predictors of mortality in patients treated with long-term oxygen therapy. Respir Med 2011; 105(3):470-476.
22. Martínez FJ, Foster G, Curtis JL, et al; NETT Research Group. Predictors of mortality in patients with emphysema and severe airfl ow obstruction. Am J Respir Crit Care Med 2006; 173(12):1326-1334.
23. Rasmussen L, Christensen S, Lenler-Petersen P, et al. Anemia and 90-day mortality in copd patients requiring invasive mechanical ventilation. Clin Epidemiol 2011; 3:1-5.
24. Rodríguez-Roisin R. Toward a consensus defi nition for copd exacerbation. Chest 2000; 117(suppl 2):398-401s.
25. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Th orax 1999; 54(3):581-586.
26. Ferrer M, Alonso J, Prieto L, et al. Validity and reliability of the St. George's Respiratory Questionnaire after adaptation to a diff erent language and culture: The Spanish example. Eur Respir J 1996; 9(6):1160-1166.
27. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic co-morbidity inlongitudinal studies: Development and validation. J Chronic Dis 1987; 40(5):373-378.
28. Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis-part I: Review of principles and methods. Clin Nutr 2004; 23(5):1226-1243.
29. WHO. Iron defi cency anemia: Assesment, prevention and control: A guide for program manager. Geneva: WHO; 2001.
30. Guralnik JM, Ersshler WB, Schrier SL, et al. Anemia in the elderly: A public health crisis in hematology. Hematol Am Soc Hematol Educ Prog 2005; (1):528-532.
31. Seneff MG, Wagner DP, Wagner RP, et al. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 1995; 274(23):1852-1857.
32. Connors AF, Dawson NV, Th omas C, et al. Outcomes following acute exacerbation of severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154(4Pt 1):959-967.
33. Sin DD, Anthonisen NR, Soriano JB, et al. Mortality in copd: Role of co-morbidities. Eur Respir J 2006; 28(6):1245-1257.
34. Fremault A, Janssens W, Beaucage F, et al. Modifi cation of copd presentation during the last 25 years. copd 2010; 7(5):345-351.
35. Soler-Catalũa JJ, Martínez-García MA, Catalán Serra P. Impacto multidimensional de las exacerbaciones de la EPOC. Arch Bronconeumol 2010; 46(Suppl.11) :12-19.
36. Portillo K. Anemia in copd: Should it be taken into consideration? Arch Bronconeumol 2007; 43(7):392-398.
37. Similowski T, Agusti A, MacNee W, et al. The potential impact of anaemia of chronic disease in copd. Eur Respir J 2006; 27(2):390-396.
38. Young JB, Abraham WT, Albert NM, et al. Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry). Am J Cardiol 2008; 101(2):223-230.
39. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airfl ow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350(10):1005-1012.
40. Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: The future of copd. Am J Respir Crit Care Med 2010; 182(5):598-604.